Search In this Thesis
   Search In this Thesis  
العنوان
Therapeutic Challenges of Conventional and Nanoparticles of Some Novel Antimetabolic Agents in Treatment of Cancer \
المؤلف
Hassan, Ashraf Elsayed Mohamed.
هيئة الاعداد
باحث / Ashraf El-Sayed Mohamed
مشرف / . Samah Ali Loutfy
مشرف / . Galal Hamza Elgem
مشرف / Doaa Madbouly Massoud Ali
مشرف / Doaa Madbouly Massoud Ali
الموضوع
Nanoparticles. Antimetabolites.
تاريخ النشر
2020
عدد الصفحات
1 VOL. (various paging’s) :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
Multidisciplinary تعددية التخصصات
تاريخ الإجازة
1/12/2020
مكان الإجازة
جامعة حلوان - كلية العلوم - Chemistr
الفهرس
Only 14 pages are availabe for public view

from 254

from 254

Abstract

A series of novel pyrazolopyrimidine and pyrazololpyridine thioglycoside were synthesized and confirmed via their spectral analyses. the effect of these anti-metabolic compounds were evaluated against proliferation of Huh-7 and Mcf-7 as in vitro models of human liver and breast cancers, respectively. Vero cells were used as an example of normal green monkey kidney cells. The most promising compound was subjected to a Nano formulation by its encapsulation into chitosan nanoparticles to increase its anti-cancerous activity. Nano formulation was confirmed by TEM and FT-IR to ensure encapsulation and screened for their cytotoxicity against Huh-7 and Mcf-7 cells using MTT colorimetric assay and morphological examination. Genotoxic effect was performed by cellular DNA fragmentation assay. Simulated CompuSyn software (linear interaction effect) was conducted to predict the possible synergistic effect of nanocomposite as anticancerous activity. Apoptotic effect was further analyzed by detection of apoptotic proteins using ELISA assay. our results showed that the nano preparation was successfully prepared by encapsulation of compound 14 into chitosan nanoparticles, controlled to a size at 105 nm and zeta charges at 40.2 mV. Treatment of Huh-7 and Mcf-7 showed that compound 14 was the most cytotoxic compound on both cancer cell lines where IC50 was 24.59 (9.836 μg/mL) and 12.203 (4.8812 μg/mL) on Huh-7 and Mcf-7 respectively. But IC50 of the nano preparation was 37.19 and 30.68 μg/mL on Huh-7 and Mcf-7, respectively, indicating its aggressiveness on human breast cancer cells as confirmed by DNA fragmentation assay and theoretically by CompuSyn tool. from all that we Concluded that a novel series of pyrazolopyrimidine thioglycosides and pyrazolopyridine thioglycosides were synthesized.Nanoformulation of compound 14 into chitosan nanoparticles demonstrated anticancer activity and can be used as a drug delivery system, but further studies are still required